{
    "abstract": "Glycoconjugate vaccines are made of carbohydrate antigens covalently bound to a carrier protein to enhance their immunogenicity. Among the different carrier proteins tested in preclinical and clinical studies, five have been used so far for licensed vaccines: Diphtheria and Tetanus toxoids, the non-toxic mutant of diphtheria toxin CRM197, the outer membrane protein complex of Neisseria meningitidis serogroup B and the Protein D derived from non-typeable Haemophilus influenzae. Availability of novel carriers might help to overcome immune interference in multi-valent vaccines containing several polysaccharide-conjugate antigens, and also to develop vaccines which target both protein as well saccharide epitopes of the same pathogen. Accordingly we have conducted a study to identify new potential carrier proteins. Twenty-eight proteins, derived from different bacteria, were conjugated to the model polysaccharide Laminarin and tested in mice for their ability in inducing antibodies against the carbohydrate antigen and eight of them were subsequently tested as carrier for serogroup meningococcal C oligosaccharides. Four out of these eight were able to elicit in mice satisfactory anti meningococcal serogroup C titers. Based on immunological evaluation, the Streptococcus pneumoniae protein spr96/2021 was successfully evaluated as carrier for serogroups A, C, W, Y and X meningococcal capsular saccharides.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Barrera"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Sutton"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                }
            ],
            "doi": "10.1084/jem.152.2.361",
            "firstpage": "361",
            "issn": "00221007",
            "lastpage": "376",
            "pmid": "6967514",
            "pub_year": 1980,
            "title": "Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates",
            "volume": "152"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                }
            ],
            "doi": "10.1517/17460441.2011.609554",
            "firstpage": "1045",
            "issn": "17460441",
            "lastpage": "1066",
            "pub_year": 2011,
            "title": "The design of semi-synthetic and synthetic glycoconjugate vaccines",
            "volume": "6"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                }
            ],
            "doi": "10.1021/cb400423g",
            "firstpage": "1653",
            "issn": "15548929",
            "lastpage": "1663",
            "pmid": "23841819",
            "pub_year": 2013,
            "title": "Recent mechanistic insights on glycoconjugate vaccines and future perspectives",
            "volume": "8"
        },
        "b0020": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Pace"
                }
            ],
            "firstpage": "692",
            "issn": "14648431",
            "lastpage": "706",
            "pmid": "20072946",
            "pub_year": 2009,
            "title": "MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection",
            "volume": "11"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "Kirsten P.",
                    "initial": "K.P.",
                    "last": "Perrett"
                },
                {
                    "first": "Karen J.",
                    "initial": "K.J.",
                    "last": "Ford"
                },
                {
                    "first": "Tessa M.",
                    "initial": "T.M.",
                    "last": "John"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Pace"
                },
                {
                    "first": "Ly Mee",
                    "initial": "L.M.",
                    "last": "Yu"
                },
                {
                    "first": "Joanne M.",
                    "initial": "J.M.",
                    "last": "Langley"
                },
                {
                    "first": "Shelley",
                    "initial": "S.",
                    "last": "McNeil"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Ceddia"
                },
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "Anemona"
                },
                {
                    "first": "Scott A.",
                    "initial": "S.A.",
                    "last": "Halperin"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Dobson"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1001/jama.2007.29-c",
            "firstpage": "173",
            "issn": "00987484",
            "lastpage": "184",
            "pmid": "18182599",
            "pub_year": 2008,
            "title": "Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: A randomized controlled trial",
            "volume": "299"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Jens U.",
                    "initial": "J.U.",
                    "last": "R\u00fcggeberg"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.2165/00148581-200406040-00004",
            "firstpage": "251",
            "issn": "11745878",
            "lastpage": "266",
            "pmid": "15339202",
            "pub_year": 2004,
            "title": "Meningococcal vaccines",
            "volume": "6"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "\u00d8stergaard"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Lebacq"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Gudrun",
                    "initial": "G.",
                    "last": "Maechler"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.08.075",
            "firstpage": "161",
            "issn": "0264410X",
            "lastpage": "168",
            "pmid": "18834910",
            "pub_year": 2009,
            "title": "Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years",
            "volume": "27"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Carola",
                    "initial": "C.",
                    "last": "Neum\u00fcller"
                }
            ],
            "doi": "10.1038/174405a0",
            "firstpage": "405",
            "issn": "00280836",
            "lastpage": "406",
            "pmid": "13194008",
            "pub_year": 1954,
            "title": "Detoxification of diphtheria toxin with formaldehyde mixed with an amino-acid",
            "volume": "174"
        },
        "b0045": {
            "authors": [
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Giannini"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Ratti"
                }
            ],
            "doi": "10.1093/nar/12.10.4063",
            "firstpage": "4063",
            "issn": "03051048",
            "lastpage": "4069",
            "pmid": "6427753",
            "pub_year": 1984,
            "title": "The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197",
            "volume": "12"
        },
        "b0050": {
            "authors": [
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Donnelly"
                },
                {
                    "first": "R. R.",
                    "initial": "R.R.",
                    "last": "Deck"
                },
                {
                    "first": "M. A.",
                    "initial": "M.A.",
                    "last": "Liu"
                }
            ],
            "firstpage": "3071",
            "issn": "00221767",
            "lastpage": "3079",
            "pmid": "2120344",
            "pub_year": 1990,
            "title": "Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine",
            "volume": "145"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1586/erv.09.113",
            "firstpage": "1479",
            "issn": "14760584",
            "lastpage": "1500",
            "pmid": "19863240",
            "pub_year": 2009,
            "title": "10-Valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix\u2122",
            "volume": "8"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "Forsgren"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                },
                {
                    "first": "H\u00e5kan",
                    "initial": "H.",
                    "last": "Janson"
                }
            ],
            "doi": "10.1086/527396",
            "firstpage": "726",
            "issn": "10584838",
            "lastpage": "731",
            "pmid": "18230042",
            "pub_year": 2008,
            "title": "Protein D of Haemophilus influenzae: A protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines",
            "volume": "46"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Karl",
                    "initial": "K.",
                    "last": "Pobre"
                },
                {
                    "first": "Mohamed",
                    "initial": "M.",
                    "last": "Tashani"
                },
                {
                    "first": "Iman",
                    "initial": "I.",
                    "last": "Ridda"
                },
                {
                    "first": "Harunor",
                    "initial": "H.",
                    "last": "Rashid"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Wong"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Booy"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.01.047",
            "firstpage": "1423",
            "issn": "0264410X",
            "lastpage": "1430",
            "pmid": "24492014",
            "pub_year": 2014,
            "title": "Carrier priming or suppression: Understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines",
            "volume": "32"
        },
        "b0070": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Pecetta"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Lo Surdo"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Zambonelli"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Bottomley"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Biagini"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Buricchi"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Donnarumma"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Norais"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2014.11.026",
            "firstpage": "314",
            "issn": "0264410X",
            "lastpage": "320",
            "pmid": "25448110",
            "pub_year": 2015,
            "title": "Carrier priming with CRM197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation",
            "volume": "33"
        },
        "b0075": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Zambonelli"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Bottomley"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "De Gregorio"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Del Giudice"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.07.078",
            "firstpage": "4827",
            "issn": "0264410X",
            "lastpage": "4833",
            "pmid": "23965218",
            "pub_year": 2013,
            "title": "Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines",
            "volume": "31"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.06.026",
            "firstpage": "5513",
            "issn": "0264410X",
            "lastpage": "5523",
            "pmid": "20600514",
            "pub_year": 2010,
            "title": "Glycoconjugate vaccines and immune interference: A review",
            "volume": "28"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Dani",
                    "initial": "D.",
                    "last": "Cohen"
                },
                {
                    "first": "Shai",
                    "initial": "S.",
                    "last": "Ashkenazi"
                },
                {
                    "first": "Manfred S.",
                    "initial": "M.S.",
                    "last": "Green"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Gdalevich"
                },
                {
                    "first": "Guy",
                    "initial": "G.",
                    "last": "Robin"
                },
                {
                    "first": "Raphael",
                    "initial": "R.",
                    "last": "Slepon"
                },
                {
                    "first": "Miri",
                    "initial": "M.",
                    "last": "Yavzori"
                },
                {
                    "first": "Nadav",
                    "initial": "N.",
                    "last": "Orr"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Block"
                },
                {
                    "first": "Isaac",
                    "initial": "I.",
                    "last": "Ashkenazi"
                },
                {
                    "first": "Joshua",
                    "initial": "J.",
                    "last": "Shemer"
                },
                {
                    "first": "David N.",
                    "initial": "D.N.",
                    "last": "Taylor"
                },
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Hale"
                },
                {
                    "first": "Jerald C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "Danka",
                    "initial": "D.",
                    "last": "Pavliakova"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                }
            ],
            "doi": "10.1016/S0140-6736(96)06255-1",
            "firstpage": "155",
            "issn": "01406736",
            "lastpage": "159",
            "pmid": "9111538",
            "pub_year": 1997,
            "title": "Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults",
            "volume": "349"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Zuzana",
                    "initial": "Z.",
                    "last": "Kossaczka"
                },
                {
                    "first": "Feng Ying C.",
                    "initial": "F.Y.C.",
                    "last": "Lin"
                },
                {
                    "first": "Vo\u030a Anh",
                    "initial": "V.A.",
                    "last": "Ho"
                },
                {
                    "first": "Nguyen Thi Thanh",
                    "initial": "N.T.T.",
                    "last": "Thuy"
                },
                {
                    "first": "Phan",
                    "initial": "P.",
                    "last": "Van Bay"
                },
                {
                    "first": "Tran Cong",
                    "initial": "T.C.",
                    "last": "Thanh"
                },
                {
                    "first": "Ha Ba",
                    "initial": "H.B.",
                    "last": "Khiem"
                },
                {
                    "first": "Dang Duc",
                    "initial": "D.D.",
                    "last": "Trach"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Karpas"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Hunt"
                },
                {
                    "first": "Dolores A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Shousun C.",
                    "initial": "S.C.",
                    "last": "Szu"
                }
            ],
            "doi": "10.1128/iai.67.11.5806-5810.1999",
            "firstpage": "5806",
            "issn": "00199567",
            "lastpage": "5810",
            "pmid": "10531232",
            "pub_year": 1999,
            "title": "Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam",
            "volume": "67"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Shousun Chen",
                    "initial": "S.C.",
                    "last": "Szu"
                },
                {
                    "first": "Audrey L.",
                    "initial": "A.L.",
                    "last": "Stone"
                },
                {
                    "first": "Joan D.",
                    "initial": "J.D.",
                    "last": "Robbins"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                }
            ],
            "doi": "10.1084/jem.166.5.1510",
            "firstpage": "1510",
            "issn": "00221007",
            "lastpage": "1524",
            "pmid": "3681191",
            "pub_year": 1987,
            "title": "Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever: Preparation, characterization, and immunogenicity in laboratory animals",
            "volume": "166"
        },
        "b0100": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Fattom"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Watson"
                },
                {
                    "first": "W. W.",
                    "initial": "W.W.",
                    "last": "Karakawa"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Fitzgerald"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Pastan"
                },
                {
                    "first": "X.",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Shiloach"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                }
            ],
            "firstpage": "1023",
            "issn": "00199567",
            "lastpage": "1032",
            "pmid": "8432585",
            "pub_year": 1993,
            "title": "Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A",
            "volume": "61"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Christoph F.R.",
                    "initial": "C.F.R.",
                    "last": "Hatz"
                },
                {
                    "first": "Bettina",
                    "initial": "B.",
                    "last": "Bally"
                },
                {
                    "first": "Susanne",
                    "initial": "S.",
                    "last": "Rohrer"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Steffen"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Kramme"
                },
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wacker"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Alaimo"
                },
                {
                    "first": "Veronica Gambillara",
                    "initial": "V.G.",
                    "last": "Fonck"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.06.102",
            "firstpage": "4594",
            "issn": "0264410X",
            "lastpage": "4601",
            "pmid": "26162850",
            "pub_year": 2015,
            "title": "Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study",
            "volume": "33"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Fabiana",
                    "initial": "F.",
                    "last": "Falugi"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Petracca"
                },
                {
                    "first": "Massimo",
                    "initial": "M.",
                    "last": "Mariani"
                },
                {
                    "first": "Enrico",
                    "initial": "E.",
                    "last": "Luzzi"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Mancianti"
                },
                {
                    "first": "Valeria",
                    "initial": "V.",
                    "last": "Carinci"
                },
                {
                    "first": "Maria Luisa",
                    "initial": "M.L.",
                    "last": "Melli"
                },
                {
                    "first": "Oretta",
                    "initial": "O.",
                    "last": "Finco"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Wack"
                },
                {
                    "first": "Annalisa",
                    "initial": "A.",
                    "last": "Di Tommaso"
                },
                {
                    "first": "Maria Teresa",
                    "initial": "M.T.",
                    "last": "De Magistris"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                },
                {
                    "first": "Sergio",
                    "initial": "S.",
                    "last": "Abrignani"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Grandi"
                }
            ],
            "doi": "10.1002/1521-4141(200112)31:12<3816::AID-IMMU3816>3.0.CO;2-K",
            "firstpage": "3816",
            "issn": "00142980",
            "lastpage": "3824",
            "pmid": "11745403",
            "pub_year": 2001,
            "title": "Rationally designed strings of promiscuous CD4+ T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: A model for new conjugate vaccines",
            "volume": "31"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Baraldo"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Mori"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Bartoloni"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Norelli"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Grandi"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Oretta",
                    "initial": "O.",
                    "last": "Finco"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                }
            ],
            "doi": "10.1128/IAI.73.9.5835-5841.2005",
            "firstpage": "5835",
            "issn": "00199567",
            "lastpage": "5841",
            "pmid": "16113302",
            "pub_year": 2005,
            "title": "Combined conjugate vaccines: Enhanced immunogenicity with the N19 polyepitope as a carrier protein",
            "volume": "73"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Baraldo"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Mori"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Bartoloni"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Petracca"
                },
                {
                    "first": "Aldo",
                    "initial": "A.",
                    "last": "Giannozzi"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Norelli"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Grandi"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                }
            ],
            "doi": "10.1128/IAI.72.8.4884-4887.2004",
            "firstpage": "4884",
            "issn": "00199567",
            "lastpage": "4887",
            "pmid": "15271954",
            "pub_year": 2004,
            "title": "N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines",
            "volume": "72"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wacker"
                },
                {
                    "first": "Linhui",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Kowarik"
                },
                {
                    "first": "Meghan",
                    "initial": "M.",
                    "last": "Dowd"
                },
                {
                    "first": "Gerd",
                    "initial": "G.",
                    "last": "Lipowsky"
                },
                {
                    "first": "Amir",
                    "initial": "A.",
                    "last": "Faridmoayer"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Shields"
                },
                {
                    "first": "Saeyoung",
                    "initial": "S.",
                    "last": "Park"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Alaimo"
                },
                {
                    "first": "Kathryn A.",
                    "initial": "K.A.",
                    "last": "Kelley"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Braun"
                },
                {
                    "first": "Julien",
                    "initial": "J.",
                    "last": "Quebatte"
                },
                {
                    "first": "Veronica",
                    "initial": "V.",
                    "last": "Gambillara"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Carranza"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Steffen"
                },
                {
                    "first": "Jean C.",
                    "initial": "J.C.",
                    "last": "Lee"
                }
            ],
            "doi": "10.1093/infdis/jit800",
            "firstpage": "1551",
            "issn": "00221899",
            "lastpage": "1561",
            "pmid": "24308931",
            "pub_year": 2014,
            "title": "Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli",
            "volume": "209"
        },
        "b0130": {
            "authors": [
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Ginsburg"
                },
                {
                    "first": "Mark R.",
                    "initial": "M.R.",
                    "last": "Alderson"
                }
            ],
            "doi": "10.1358/dot.2011.47.3.1556471",
            "firstpage": "207",
            "issn": "16993993",
            "lastpage": "214",
            "pmid": "21494698",
            "pub_year": 2011,
            "title": "New conjugate vaccines for the prevention of pneumococcal disease in developing countries",
            "volume": "47"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Clarissa",
                    "initial": "C.",
                    "last": "Pozzi"
                },
                {
                    "first": "Katarzyna",
                    "initial": "K.",
                    "last": "Wilk"
                },
                {
                    "first": "Jean C.",
                    "initial": "J.C.",
                    "last": "Lee"
                },
                {
                    "first": "Marina",
                    "initial": "M.",
                    "last": "Gening"
                },
                {
                    "first": "Nikolay",
                    "initial": "N.",
                    "last": "Nifantiev"
                },
                {
                    "first": "Gerald B.",
                    "initial": "G.B.",
                    "last": "Pier"
                }
            ],
            "doi": "10.1371/journal.pone.0046648",
            "issn": "19326203",
            "pmid": "23077517",
            "pub_year": 2012,
            "title": "Opsonic and Protective Properties of Antibodies Raised to Conjugate Vaccines Targeting Six Staphylococcus aureus Antigens",
            "volume": "7"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Maria R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Rosanna",
                    "initial": "R.",
                    "last": "Leuzzi"
                },
                {
                    "first": "Emilia",
                    "initial": "E.",
                    "last": "Cappelletti"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Nilo"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Scarselli"
                }
            ],
            "doi": "10.3390/toxins6041385",
            "firstpage": "1385",
            "issn": "20726651",
            "lastpage": "1396",
            "pmid": "24759173",
            "pub_year": 2014,
            "title": "Recombinant clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity",
            "volume": "6"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Neha",
                    "initial": "N.",
                    "last": "Kothari"
                },
                {
                    "first": "Sudeep",
                    "initial": "S.",
                    "last": "Kothari"
                },
                {
                    "first": "Young Joo",
                    "initial": "Y.J.",
                    "last": "Choi"
                },
                {
                    "first": "Ayan",
                    "initial": "A.",
                    "last": "Dey"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Briles"
                },
                {
                    "first": "Dong Kwon",
                    "initial": "D.K.",
                    "last": "Rhee"
                },
                {
                    "first": "Rodney",
                    "initial": "R.",
                    "last": "Carbis"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.12.032",
            "firstpage": "783",
            "issn": "0264410X",
            "lastpage": "788",
            "pmid": "25545593",
            "pub_year": 2015,
            "title": "A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi",
            "volume": "33"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Nilo"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Morelli"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "Passalacqua"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Brogioni"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Allan"
                },
                {
                    "first": "Filippo",
                    "initial": "F.",
                    "last": "Carboni"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Pezzicoli"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Zerbini"
                },
                {
                    "first": "Domenico",
                    "initial": "D.",
                    "last": "Maione"
                },
                {
                    "first": "Monica",
                    "initial": "M.",
                    "last": "Fabbrini"
                },
                {
                    "first": "Maria Rosaria",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Qi Ying",
                    "initial": "Q.Y.",
                    "last": "Hu"
                },
                {
                    "first": "Immaculada",
                    "initial": "I.",
                    "last": "Margarit"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                }
            ],
            "doi": "10.1021/acschembio.5b00247",
            "firstpage": "1737",
            "issn": "15548929",
            "lastpage": "1746",
            "pmid": "25906283",
            "pub_year": 2015,
            "title": "Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation",
            "volume": "10"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Bromuro"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Romano"
                },
                {
                    "first": "Paola",
                    "initial": "P.",
                    "last": "Chiani"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Mori"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Torosantucci"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Cassone"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.01.012",
            "firstpage": "2615",
            "issn": "0264410X",
            "lastpage": "2623",
            "pmid": "20096763",
            "pub_year": 2010,
            "title": "Beta-glucan-CRM197 conjugates as candidates antifungal vaccines",
            "volume": "28"
        },
        "b0160": {
            "authors": [
                {
                    "first": "A. F.S.A.",
                    "initial": "A.F.S.A.",
                    "last": "Habeeb"
                }
            ],
            "doi": "10.1016/0003-2697(66)90275-2",
            "firstpage": "328",
            "issn": "00032697",
            "lastpage": "336",
            "pmid": "4161471",
            "pub_year": 1966,
            "title": "Determination of free amino groups in proteins by trinitrobenzenesulfonic acid",
            "volume": "14"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Max",
                    "initial": "M.",
                    "last": "Hill"
                },
                {
                    "first": "Jean Jacques",
                    "initial": "J.J.",
                    "last": "Bechet"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "d'Albis"
                }
            ],
            "doi": "10.1016/0014-5793(79)80019-8",
            "firstpage": "282",
            "issn": "00145793",
            "lastpage": "286",
            "pmid": "456607",
            "pub_year": 1979,
            "title": "Disuccinimidyl esters as bifunctional crosslinking reagents for proteins. Assays with myosin",
            "volume": "102"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Talia",
                    "initial": "T.",
                    "last": "Miron"
                },
                {
                    "first": "Meir",
                    "initial": "M.",
                    "last": "Wilchek"
                }
            ],
            "doi": "10.1016/0003-2697(82)90540-1",
            "firstpage": "433",
            "issn": "00032697",
            "lastpage": "435",
            "pmid": "7158777",
            "pub_year": 1982,
            "title": "A spectrophotometric assay for soluble and immobilized N-hydroxysuccinimide esters",
            "volume": "126"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Br\u00f6ker"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.07.036",
            "firstpage": "5574",
            "issn": "0264410X",
            "lastpage": "5580",
            "pmid": "19619500",
            "pub_year": 2009,
            "title": "Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages",
            "volume": "27"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Micoli"
                },
                {
                    "first": "Maria Rosaria",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "Emilia",
                    "initial": "E.",
                    "last": "Cappelletti"
                },
                {
                    "first": "Massimiliano",
                    "initial": "M.",
                    "last": "Gavini"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "Simona",
                    "initial": "S.",
                    "last": "Rondini"
                },
                {
                    "first": "Erwin",
                    "initial": "E.",
                    "last": "Swennen"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Santini"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Filippini"
                },
                {
                    "first": "Cristiana",
                    "initial": "C.",
                    "last": "Balocchi"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                },
                {
                    "first": "Gerd",
                    "initial": "G.",
                    "last": "Pluschke"
                },
                {
                    "first": "Gunnstein",
                    "initial": "G.",
                    "last": "Norheim"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Pollard"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "Saul"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Calman A.",
                    "initial": "C.A.",
                    "last": "MacLennan"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1073/pnas.1314476110",
            "firstpage": "19077",
            "issn": "00278424",
            "lastpage": "19082",
            "pmid": "24191022",
            "pub_year": 2013,
            "title": "Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X",
            "volume": "110"
        },
        "b0185": {
            "authors": [
                {
                    "first": "P. K.",
                    "initial": "P.K.",
                    "last": "Smith"
                },
                {
                    "first": "R. I.",
                    "initial": "R.I.",
                    "last": "Krohn"
                },
                {
                    "first": "G. T.",
                    "initial": "G.T.",
                    "last": "Hermanson"
                },
                {
                    "first": "A. K.",
                    "initial": "A.K.",
                    "last": "Mallia"
                },
                {
                    "first": "F. H.",
                    "initial": "F.H.",
                    "last": "Gartner"
                },
                {
                    "first": "M. D.",
                    "initial": "M.D.",
                    "last": "Provenzano"
                },
                {
                    "first": "E. K.",
                    "initial": "E.K.",
                    "last": "Fujimoto"
                },
                {
                    "first": "N. M.",
                    "initial": "N.M.",
                    "last": "Goeke"
                },
                {
                    "first": "B. J.",
                    "initial": "B.J.",
                    "last": "Olson"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Klenk"
                }
            ],
            "doi": "10.1016/0003-2697(85)90442-7",
            "firstpage": "76",
            "issn": "00032697",
            "lastpage": "85",
            "pmid": "3843705",
            "pub_year": 1985,
            "title": "Measurement of protein using bicinchoninic acid",
            "volume": "150"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Jackson"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Baxter"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Reisinger"
                },
                {
                    "first": "Annette",
                    "initial": "A.",
                    "last": "Karsten"
                },
                {
                    "first": "Jina",
                    "initial": "J.",
                    "last": "Shah"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Bedell"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                }
            ],
            "doi": "10.1086/599117",
            "firstpage": "e1",
            "issn": "10584838",
            "lastpage": "e10",
            "pmid": "19476428",
            "pub_year": 2009,
            "title": "Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents",
            "volume": "49"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Qing",
                    "initial": "Q.",
                    "last": "Zhang"
                },
                {
                    "first": "Peng",
                    "initial": "P.",
                    "last": "Wang"
                },
                {
                    "first": "Yohan",
                    "initial": "Y.",
                    "last": "Kim"
                },
                {
                    "first": "Pernille",
                    "initial": "P.",
                    "last": "Haste-Andersen"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Beaver"
                },
                {
                    "first": "Philip E.",
                    "initial": "P.E.",
                    "last": "Bourne"
                },
                {
                    "first": "Huynh Hoa",
                    "initial": "H.H.",
                    "last": "Bui"
                },
                {
                    "first": "Soren",
                    "initial": "S.",
                    "last": "Buus"
                },
                {
                    "first": "Sune",
                    "initial": "S.",
                    "last": "Frankild"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Greenbaum"
                },
                {
                    "first": "Ole",
                    "initial": "O.",
                    "last": "Lund"
                },
                {
                    "first": "Claus",
                    "initial": "C.",
                    "last": "Lundegaard"
                },
                {
                    "first": "Morten",
                    "initial": "M.",
                    "last": "Nielsen"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Ponomarenko"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                },
                {
                    "first": "Zhanyang",
                    "initial": "Z.",
                    "last": "Zhu"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                }
            ],
            "doi": "10.1093/nar/gkn254",
            "firstpage": "W513",
            "issn": "13624962",
            "lastpage": "518",
            "pmid": "18515843",
            "pub_year": 2008,
            "title": "Immune epitope database analysis resource (IEDB-AR).",
            "volume": "36"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Torosantucci"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Bromuro"
                },
                {
                    "first": "Paola",
                    "initial": "P.",
                    "last": "Chiani"
                },
                {
                    "first": "Flavia",
                    "initial": "F.",
                    "last": "De Bernardis"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Chiara",
                    "initial": "C.",
                    "last": "Galli"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Norelli"
                },
                {
                    "first": "Cinzia",
                    "initial": "C.",
                    "last": "Bellucci"
                },
                {
                    "first": "Luciano",
                    "initial": "L.",
                    "last": "Polonelli"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Cassone"
                }
            ],
            "doi": "10.1084/jem.20050749",
            "firstpage": "597",
            "issn": "00221007",
            "lastpage": "606",
            "pmid": "16147975",
            "pub_year": 2005,
            "title": "A novel glyco-conjugate vaccine against fungal pathogens",
            "volume": "202"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "Giulia",
                    "initial": "G.",
                    "last": "Brogioni"
                },
                {
                    "first": "Maria Rosaria",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Gabriele",
                    "initial": "G.",
                    "last": "Costantini"
                },
                {
                    "first": "Elisa",
                    "initial": "E.",
                    "last": "Danieli"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1080/07328303.2011.604453",
            "firstpage": "249",
            "issn": "07328303",
            "lastpage": "280",
            "pub_year": 2011,
            "title": "Synthesis of laminarin fragments and evaluation of a \u03b2-(1,3) glucan hexasaccaride-CRM 197 conjugate as vaccine candidate against Candida albicans",
            "volume": "30"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Alfonso",
                    "initial": "A.",
                    "last": "Olaya-Abril"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "Jim\u00e9nez-Mungu\u00eda"
                },
                {
                    "first": "Lidia",
                    "initial": "L.",
                    "last": "G\u00f3mez-Gasc\u00f3n"
                },
                {
                    "first": "Ignacio",
                    "initial": "I.",
                    "last": "Obando"
                },
                {
                    "first": "Manuel J.",
                    "initial": "M.J.",
                    "last": "Rodr\u00edguez-Ortega"
                }
            ],
            "doi": "10.1371/journal.pone.0070365",
            "issn": "19326203",
            "pmid": "23894641",
            "pub_year": 2013,
            "title": "Identification of Potential New Protein Vaccine Candidates through Pan-Surfomic Analysis of Pneumococcal Clinical Isolates from Adults",
            "volume": "8"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Cardaci"
                },
                {
                    "first": "Salvatore",
                    "initial": "S.",
                    "last": "Papasergi"
                },
                {
                    "first": "Angelina",
                    "initial": "A.",
                    "last": "Midiri"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Mancuso"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Domina"
                },
                {
                    "first": "Veronica Lanza",
                    "initial": "V.L.",
                    "last": "Cariccio"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Mandanici"
                },
                {
                    "first": "Roberta",
                    "initial": "R.",
                    "last": "Galbo"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Lo Passo"
                },
                {
                    "first": "Ida",
                    "initial": "I.",
                    "last": "Pernice"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Donato"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Ricci"
                },
                {
                    "first": "Carmelo",
                    "initial": "C.",
                    "last": "Biondo"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Teti"
                },
                {
                    "first": "Franco",
                    "initial": "F.",
                    "last": "Felici"
                },
                {
                    "first": "Concetta",
                    "initial": "C.",
                    "last": "Beninati"
                }
            ],
            "doi": "10.1371/journal.pone.0036588",
            "issn": "19326203",
            "pmid": "22570729",
            "pub_year": 2012,
            "title": "Protective activity of Streptococcus pneumoniae spr1875 protein fragments identified using a phage displayed genomic library",
            "volume": "7"
        },
        "b0220": null,
        "b0225": {
            "authors": [
                {
                    "first": "Marzia M.",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Jeannette",
                    "initial": "J.",
                    "last": "Adu-Bobie"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "Comanducci"
                },
                {
                    "first": "Beatrice",
                    "initial": "B.",
                    "last": "Aric\u00f2"
                },
                {
                    "first": "Silvana",
                    "initial": "S.",
                    "last": "Savino"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Santini"
                },
                {
                    "first": "Brunella",
                    "initial": "B.",
                    "last": "Brunelli"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Bambini"
                },
                {
                    "first": "Alessia",
                    "initial": "A.",
                    "last": "Biolchi"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Capecchi"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Cartocci"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Ciucchi"
                },
                {
                    "first": "Federica",
                    "initial": "F.",
                    "last": "Di Marcello"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Ferlicca"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Galli"
                },
                {
                    "first": "Enrico",
                    "initial": "E.",
                    "last": "Luzzi"
                },
                {
                    "first": "Vega",
                    "initial": "V.",
                    "last": "Masignani"
                },
                {
                    "first": "Davide",
                    "initial": "D.",
                    "last": "Serruto"
                },
                {
                    "first": "Daniele",
                    "initial": "D.",
                    "last": "Veggi"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Contorni"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "Morandi"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Bartalesi"
                },
                {
                    "first": "Vanda",
                    "initial": "V.",
                    "last": "Cinotti"
                },
                {
                    "first": "Donatella",
                    "initial": "D.",
                    "last": "Mannucci"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Titta"
                },
                {
                    "first": "Elisa",
                    "initial": "E.",
                    "last": "Ovidi"
                },
                {
                    "first": "Jo Anne",
                    "initial": "J.A.",
                    "last": "Welsch"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Granoff"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                }
            ],
            "doi": "10.1073/pnas.0603940103",
            "firstpage": "10834",
            "issn": "00278424",
            "lastpage": "10839",
            "pmid": "16825336",
            "pub_year": 2006,
            "title": "A universal vaccine for serogroup B meningococcus",
            "volume": "103"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Cooper"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Detora"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Stoddard"
                }
            ],
            "doi": "10.1586/erv.10.147",
            "firstpage": "21",
            "issn": "14760584",
            "lastpage": "33",
            "pmid": "21162617",
            "pub_year": 2011,
            "title": "Menveo\u00ae: A novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and y",
            "volume": "10"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Jamie D.",
                    "initial": "J.D.",
                    "last": "Croxtall"
                },
                {
                    "first": "Sohita",
                    "initial": "S.",
                    "last": "Dhillon"
                }
            ],
            "doi": "10.2165/11209580-000000000-00000",
            "firstpage": "2407",
            "issn": "00126667",
            "lastpage": "2430",
            "pmid": "23231026",
            "pub_year": 2012,
            "title": "Meningococcal quadrivalent (Serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix\u2122)",
            "volume": "72"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Vega",
                    "initial": "V.",
                    "last": "Masignani"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Lattanzi"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00209-3",
            "firstpage": "S110",
            "issn": "0264410X",
            "lastpage": "S113",
            "pmid": "12763692",
            "pub_year": 2003,
            "title": "The value of vaccines",
            "volume": "21"
        }
    },
    "body_text": [
        {
            "endOffset": 20938,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Groups of 6\u20138 mice (BALB/c or CD1) were immunized subcutaneously on days 1, 14 and 28; bleedings were performed on day 0 (pre immune), day 27 (post 2) and day 42 (post 3).",
            "startOffset": 20767,
            "title": "Mice immunization"
        },
        {
            "endOffset": 21311,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Control groups received PBS alone or PBS/adjuvant.",
            "startOffset": 21261,
            "title": "Mice immunization"
        },
        {
            "endOffset": 26388,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0195": {
                    "endOffset": 26368,
                    "startOffset": 26364
                }
            },
            "secId": "s0055",
            "sentence": "Investigation on MHC II high affinity binding peptides on the proteins has been done by IEDB Analysis Resource [39], as reported in SI.",
            "startOffset": 26253,
            "title": "MHC II binding prediction"
        },
        {
            "endOffset": 37328,
            "parents": [],
            "secId": "s0085",
            "sentence": "As well as the number of MHC II high affinity binding peptides, other factors like the glycoconjugate processing inside the antigen presenting cells, the strength of the interaction with the T-cell receptor, the chemical glycosylation procedure, the extent and localization of glycosylation, might affect the integrity of the key T-cell epitopes, therefore determining the immunogenicity of the conjugate.",
            "startOffset": 36923,
            "title": "Discussion"
        },
        {
            "endOffset": 31134,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Interestingly also Upec-5211, Orf3526, and spr1875 conjugates response was comparable to the control (p > 0.05), while GNA2091-fHbp, RrgB I-II-III, spr907 and spr1418 conjugates were inferior to the control (p < 0.01) (Fig. 2).",
            "startOffset": 30907,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 36835,
            "parents": [],
            "secId": "s0085",
            "sentence": "The role of the carrier in glycoconjugate vaccines is to provide T-cell epitopes which bind to the class II MHC and subsequently, on the surface of the antigen presenting cells, interact with the CD4+ T cell receptor to trigger signals which induce B-cell differentiation in carbohydrate-specific plasma and memory cells.",
            "startOffset": 36514,
            "title": "Discussion"
        },
        {
            "endOffset": 27488,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The activated oligosaccharide was then reacted with the different proteins using the same active ester/protein molar ratio (Scheme 1).",
            "startOffset": 27354,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 36922,
            "parents": [],
            "secId": "s0085",
            "sentence": "Many factors are important in determining the ability of a protein to work as carrier.",
            "startOffset": 36836,
            "title": "Discussion"
        },
        {
            "endOffset": 39136,
            "parents": [],
            "secId": "s0085",
            "sentence": "Moreover the glycosylation profile of the fusion protein could be different for the fusion and single proteins, leading to a different impact on the preservation of T-cell epitopes and/or the conjugates processing inside the antigen presenting cells; we are currently investigating this aspect.",
            "startOffset": 38842,
            "title": "Discussion"
        },
        {
            "endOffset": 13801,
            "parents": [],
            "secId": "s0005",
            "sentence": "Other proteins are increasingly used as carrier and some of them have also been tested in clinical trials.",
            "startOffset": 13695,
            "title": "Introduction"
        },
        {
            "endOffset": 23288,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "After 30 min of incubation at room temperature, plates were read at 405 nm using a Biorad plate reader.",
            "startOffset": 23185,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 15607,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 15606,
                    "startOffset": 15602
                }
            },
            "secId": "s0005",
            "sentence": "Laminarin (Lam) was the model saccharide used for the first immunogenicity screening, a neutral sugar antigen studied as vaccine candidate against infections induced by Candida albicans [31].",
            "startOffset": 15416,
            "title": "Introduction"
        },
        {
            "endOffset": 15808,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Serogroup A, C, W, Y meningococcal oligosaccharides were provided by the Manufacturing Department (GSK, Siena, Italy).",
            "startOffset": 15690,
            "title": "Reagents"
        },
        {
            "endOffset": 20214,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 20213,
                    "startOffset": 20209
                }
            },
            "secId": "s0025",
            "sentence": "Men X polysaccharide was size reduced and activated for the conjugation as reported before [36].",
            "startOffset": 20118,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 28400,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In each immunogenicity study a control group of mice was immunized with CRM197\u2013Lam.",
            "startOffset": 28317,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 11938,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 11937,
                    "startOffset": 11932
                },
                "b0010": {
                    "endOffset": 11937,
                    "startOffset": 11932
                },
                "b0015": {
                    "endOffset": 11937,
                    "startOffset": 11932
                }
            },
            "secId": "s0005",
            "sentence": "Glycoconjugate vaccines are safe and efficacious tools to prevent infection and mortality against different encapsulated bacterial pathogens [1\u20133].",
            "startOffset": 11791,
            "title": "Introduction"
        },
        {
            "endOffset": 16865,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Sp proteins were identified as spr when derived from R6 genome or D39 (spr1418 and spr1712), non spr are derived from TIGR4 genome or INV104 genome (PitB).",
            "startOffset": 16710,
            "title": "Preparation of protein carriers"
        },
        {
            "endOffset": 27854,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS\u2013Page) the glycoconjugates appeared with a typical smear, due to the variable number of sugar chains bound to the protein and to the polydispersion of the sugar chain length; an example is reported in Fig. 1 SI.",
            "startOffset": 27578,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 40466,
            "parents": [],
            "secId": "s0090",
            "sentence": "All authors are employees of the GSK group of companies.",
            "startOffset": 40410,
            "title": "Conflict of interests"
        },
        {
            "endOffset": 18215,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Lam conjugates have been prepared in 10\u2013100 mM NaH2PO4 pH 7 or in phosphate buffer saline pH 7 (PBS, 150 mM NaCl, 10 mM Na2HPO4, 2 mM KCl, 2 mM KH2PO4) depending on the protein buffer, using an active ester (AE):protein molar ratio of 30:1, and a protein concentration in the range of 0.4\u20136 mg/ml.",
            "startOffset": 17918,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 20613,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 20612,
                    "startOffset": 20608
                }
            },
            "secId": "s0025",
            "sentence": "CRM197\u2013Men X conjugate was prepared as previously published [36].",
            "startOffset": 20548,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 37577,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 37416,
                    "startOffset": 37412
                }
            },
            "secId": "s0085",
            "sentence": "By applying the MHC class II prediction algorithms IEDB Analysis Resource (IEDB-AR) [39] we did not find any correlation between the number of high affinity MHC II binders in the carriers and the immunogenicity of their corresponding Lam conjugates.",
            "startOffset": 37328,
            "title": "Discussion"
        },
        {
            "endOffset": 17342,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 17341,
                    "startOffset": 17337
                }
            },
            "secId": "s0025",
            "sentence": "Aminated Lam was purified by diafiltration on regenerated cellulose membrane (cut-off 1 kDa; Millipore) and the number of primary amino groups introduced were determined by colorimetric assay [32].",
            "startOffset": 17145,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 30696,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The purified glycoconjugates had a saccharide to protein ratio ranging from 0.6 to 0.1 w/w (Table 1).",
            "startOffset": 30595,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 13089,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 13088,
                    "startOffset": 13081
                },
                "b0060": {
                    "endOffset": 13088,
                    "startOffset": 13081
                }
            },
            "secId": "s0005",
            "sentence": "Protein D, derived from non-typeable H. influenzae (NTHi), has been used as carrier for most of the polysaccharides included by GSK into the multivalent pneumococcal conjugate vaccine recently licensed [11,12].",
            "startOffset": 12879,
            "title": "Introduction"
        },
        {
            "endOffset": 39584,
            "parents": [],
            "secId": "s0085",
            "sentence": "In particular spr96/2021 is a new potential protein carrier for carbohydrate haptens which might also offer pathogen-protective effect.",
            "startOffset": 39449,
            "title": "Discussion"
        },
        {
            "endOffset": 16070,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Proteins tested as new carrier candidates were produced internally by Research Center (GSK, Siena, Italy).",
            "startOffset": 15964,
            "title": "Reagents"
        },
        {
            "endOffset": 16577,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Details of cloning, expression and purification strategy are reported in SI.",
            "startOffset": 16501,
            "title": "Preparation of protein carriers"
        },
        {
            "endOffset": 12725,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 12512,
                    "startOffset": 12509
                }
            },
            "secId": "s0005",
            "sentence": "CRM197, a non-toxic mutant of diphtheria toxin [9], has been extensively used as carrier for licensed conjugate vaccines against Haemophilus influenzae type b (Hib), Streptococcus pneumoniae, Neisseria meningitidis) and for other vaccines in clinical development.",
            "startOffset": 12462,
            "title": "Introduction"
        },
        {
            "endOffset": 32134,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 32133,
                    "startOffset": 32129
                }
            },
            "secId": "s0075",
            "sentence": "The conjugation to the individual Men A, Men W and Men Y oligosaccharides was carried out essentially as described above for Men C. Similarly to what already described for CRM197, the conjugation to Men X was achieved after size reduction of the polysaccharide to an average polymerization degree (avDP) of about 130 followed by random oxidation of the N-acetyl glucosamine phosphate primary hydroxyl groups and coupling of the resulting aldehyde groups to lysine \u03b5-amine groups of the protein by reductive amination (Scheme 1) [36].",
            "startOffset": 31601,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 21010,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All vaccines were administered on saccharide base in a volume of 200 \u03bcl.",
            "startOffset": 20938,
            "title": "Mice immunization"
        },
        {
            "endOffset": 25498,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "The microtiter plate was incubated for 1 h at 37 \u00b0C, then each sample was spotted in duplicate on Mueller\u2013Hinton agar plates while the controls were plated using the tilt method (time 1).",
            "startOffset": 25311,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 28546,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Only the conjugate with spr96/2021 induced an anti-Lam antibody titer significantly higher than the one induced by CRM197\u2013Lam (p = 0.01; Fig. 1).",
            "startOffset": 28401,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 20419,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Conjugation of spr96/2021 was performed at a protein concentration of 10 mg/ml with an oxidized polysaccharide to protein ratio 4:1 (w:w) and a saccharide to NaBH3CN ratio of 1:1 (w:w), at 37 \u00b0C for 48 h.",
            "startOffset": 20215,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 27353,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Lam was derivatized, at its end reducing group, with the linker succinimido diester of adipic acid (SIDEA) in such a way to have a terminal succinimido ester group available to react with the lysine residues of the proteins.",
            "startOffset": 27129,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 19050,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Conjugates have been eluted from the resin by adding 150 \u03bcl of elution buffer 0.5 M NaCl, 0.5 M NaH2PO4, 0.5 M Imidazole pH 6.3, incubating for 15 min and collecting the flow through; the elution has been repeated two times.",
            "startOffset": 18826,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 18500,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The conjugates have been purified by affinity chromatography with His MultiTrap 96-Well Filter Plates (GE Healthcare) using the His tag portion on the recombinant protein to bind the conjugate to the resin.",
            "startOffset": 18294,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 30906,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The spr96/2012 conjugate induced anti Men C polysaccharide IgG titers comparable to those developed by CRM197 conjugate (p > 0.05).",
            "startOffset": 30775,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 34925,
            "parents": [],
            "secId": "s0085",
            "sentence": "Accordingly we have conducted a screening of several bacterial proteins to investigate their potential as carrier for glycoconjugate vaccines and identify possible candidates for further development.",
            "startOffset": 34726,
            "title": "Discussion"
        },
        {
            "endOffset": 39941,
            "parents": [],
            "secId": "s0085",
            "sentence": "For a new vaccine, including conjugate vaccines, time to market is variable.",
            "startOffset": 39865,
            "title": "Discussion"
        },
        {
            "endOffset": 13695,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 13694,
                    "startOffset": 13690
                }
            },
            "secId": "s0005",
            "sentence": "Considering these aspects, novel carriers might help in avoiding or reducing the impact of the above mentioned issues and enable the further development of pediatric schedules and combinations [16].",
            "startOffset": 13497,
            "title": "Introduction"
        },
        {
            "endOffset": 21261,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Lam and Men A, C, W, Y conjugates were tested without any adjuvant while Men X conjugates were formulated with AlPO4 at 0.12 mg Al3+/dose.",
            "startOffset": 21123,
            "title": "Mice immunization"
        },
        {
            "endOffset": 19847,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Reactions were let to proceed overnight at room temperature with gentle stirring.",
            "startOffset": 19766,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 35740,
            "parents": [],
            "secId": "s0085",
            "sentence": "Spr96/2021\u2013Men C, induced anti-Men C CPS IgG titers comparable to those developed by CRM197\u2013Men C, confirming the results obtained in the Lam model.",
            "startOffset": 35592,
            "title": "Discussion"
        },
        {
            "endOffset": 24557,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Colonies were inoculated in Mueller\u2013Hinton broth, containing 0.25% glucose to reach an OD600 of 0.05\u20130.08 and incubated at 37 \u00b0C with shaking.",
            "startOffset": 24415,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 33731,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This value allows us to take in consideration only the peptides with very high affinity and obtain a useful number of peptides to compare all the proteins tested.",
            "startOffset": 33569,
            "title": "MHC II binding peptides prediction"
        },
        {
            "endOffset": 40788,
            "parents": [],
            "secId": "s0095",
            "sentence": "TM, PD, BE, MF, BC and SL acquired the data.",
            "startOffset": 40744,
            "title": "Author contributions"
        },
        {
            "endOffset": 38446,
            "parents": [],
            "secId": "s0085",
            "sentence": "It would be interesting to test conjugation chemistries that involve different amino acid residues and to analyze the glycosylation profiles of carriers conjugated to charged and non-charged saccharides, as well as the anti-carrier antibodies induced by the different conjugates.",
            "startOffset": 38167,
            "title": "Discussion"
        },
        {
            "endOffset": 23054,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "After three washes with TPBS, 100 \u03bcl/well TPBS solutions of secondary antibody alkaline phosphates conjugates (anti mouse IgG 1:10,000, Sigma\u2013Aldrich) were added and the plates incubated 1 h at 37 \u00b0C.",
            "startOffset": 22854,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 23509,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Sera titers were expressed as the reciprocal of sera dilution corresponding to a cut-off OD = 1 or to a cut-off OD = 0.2 depending on the study.",
            "startOffset": 23365,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 28810,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "As determined by ELISA on pool of sera after the third injection, and similarly to CRM197, spr96/2021 conjugate was able to induce also anti-carrier IgG, interesting information considering the potential of spr96/2021 as antigen against S. pneumoniae (Fig. 2 SI).",
            "startOffset": 28547,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 34081,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Based on this investigation we obtained, among all the proteins tested, a variable number of high affinity binder peptides, from 0 of NarE, SAG0646 and spr1287 to 68 of SPyAD.",
            "startOffset": 33906,
            "title": "MHC II binding peptides prediction"
        },
        {
            "endOffset": 17144,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Lam has been treated by reductive amination using the following conditions: 2 mg/ml of polysaccharides were incubated for 5 days at 50 \u00b0C in 300 mg/ml ammonium acetate (Sigma\u2013Aldrich) and 0.2 M sodium cyanoborohydride (NaBH3CN) (Sigma\u2013Aldrich) pH 7.5.",
            "startOffset": 16893,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 32831,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Also in this case control CRM197\u2013Men A, W, Y and X conjugates were prepared.",
            "startOffset": 32755,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 20747,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 20686,
                    "startOffset": 20682
                }
            },
            "secId": "s0025",
            "sentence": "Conjugates were characterized by micro BCA for total protein content [37] and by HPAEC-PAD analysis (SI) for total saccharide content.",
            "startOffset": 20613,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 32754,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "This is not surprising considering that the random conjugation chemistry used for this conjugate can generate cross linked products (Scheme1) and that Men X saccharide has been subject to a modest size reduction.",
            "startOffset": 32542,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 18294,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Reactions were carried out overnight at room temperature with gentle stirring.",
            "startOffset": 18216,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 38643,
            "parents": [],
            "secId": "s0085",
            "sentence": "Interestingly when the non-fusion proteins spr0096 or spr2021 were tested as Lam conjugates, no response or significantly lower than CRM197 response was induced respectively by spr0096 and spr2021.",
            "startOffset": 38446,
            "title": "Discussion"
        },
        {
            "endOffset": 26176,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "The reference strains for each meningococcal serotype used were: F8238 (Men A); C11 (Men C); 240070 (Men W); 860800 (Men Y); Z9615 (Men X).",
            "startOffset": 26037,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 14676,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 14675,
                    "startOffset": 14668
                },
                "b0130": {
                    "endOffset": 14675,
                    "startOffset": 14668
                },
                "b0135": {
                    "endOffset": 14675,
                    "startOffset": 14668
                },
                "b0140": {
                    "endOffset": 14675,
                    "startOffset": 14668
                },
                "b0145": {
                    "endOffset": 14675,
                    "startOffset": 14668
                },
                "b0150": {
                    "endOffset": 14675,
                    "startOffset": 14668
                }
            },
            "secId": "s0005",
            "sentence": "Endeavors to develop carrier proteins which might also provide protection against a target pathogen, have recently broadened to include candidates from diverse vaccine categories [25\u201330].",
            "startOffset": 14489,
            "title": "Introduction"
        },
        {
            "endOffset": 38841,
            "parents": [],
            "secId": "s0085",
            "sentence": "This behavior could be due to several factors including the different molecular weights (18.7 kDa for spr0096 and 38.9 kDa for spr2021) and the number and affinity of MHC class II binding peptides.",
            "startOffset": 38644,
            "title": "Discussion"
        },
        {
            "endOffset": 12207,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 12206,
                    "startOffset": 12201
                },
                "b0025": {
                    "endOffset": 12206,
                    "startOffset": 12201
                },
                "b0030": {
                    "endOffset": 12206,
                    "startOffset": 12201
                },
                "b0035": {
                    "endOffset": 12206,
                    "startOffset": 12201
                }
            },
            "secId": "s0005",
            "sentence": "Five carrier proteins are currently included in licensed glycoconjugate vaccines [4\u20137].",
            "startOffset": 12120,
            "title": "Introduction"
        },
        {
            "endOffset": 22032,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Lam coating has been done at 50 \u03bcg/ml of polysaccharide solution in 0.05 M Na2CO3\u2013NaHCO3 buffer at pH 9.6.",
            "startOffset": 21926,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 26036,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Typically, bacteria incubated without the test serum in the presence of complement (negative control) showed a 150\u2013200% increase in CFU/ml, during the 60 min incubation time.",
            "startOffset": 25862,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 15098,
            "parents": [],
            "secId": "s0005",
            "sentence": "Taking advantage from the availability of several recombinant proteins originated from a variety of reverse vaccinology projects undertaken in our Research Center, we have conducted a study to identify new carrier proteins, derived from different bacteria like extraintestinal pathogenic E. coli (ExPEC), N. meningitidis serogroup B (Men B), group A Streptococcus (GAS), group B Streptococcus (GBS) and S. pneumoniae (sp).",
            "startOffset": 14676,
            "title": "Introduction"
        },
        {
            "endOffset": 19380,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Non His-tag protein conjugates were purified by Ultrafiltration with Vivaspin 10 K (Sartorius).",
            "startOffset": 19285,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 29837,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Surprisingly no response was induced by the spr0096 conjugate and very low by the spr2021 one (Fig. 4 SI), indicating that some feature derived from the fusion of the two proteins is critical for the carrier activity.",
            "startOffset": 29620,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 37734,
            "parents": [],
            "secId": "s0085",
            "sentence": "Similarly we did not find a correlation between immunogenicity of the Lam conjugates and their glycosylation degree as well as the carrier molecular weight.",
            "startOffset": 37578,
            "title": "Discussion"
        },
        {
            "endOffset": 16238,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Men B 961c (NadA or GNA1994), GNA2132-1030 (NHBA-GNA1030) and GNA2091-fHbp (GNA2091\u2013GNA1870) proteins were provided by the Manufacturing Department (GSK, Siena, Italy).",
            "startOffset": 16070,
            "title": "Reagents"
        },
        {
            "endOffset": 16500,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The twenty eight recombinant proteins tested as potential new carrier candidates were expressed in E. coli, twenty five of them were expressed as His-tag fusion proteins and purified by immobilized metal affinity chromatography.",
            "startOffset": 16272,
            "title": "Preparation of protein carriers"
        },
        {
            "endOffset": 19284,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Eluted conjugates have been dialyzed with 6\u20138 kDa membrane (Spectra/Por 1, diameter 6.4 mm) against PBS buffer pH 7.2 to eliminate the elution buffer, dialysis have been carried out one day at 4 \u00b0C changing the buffer for four times.",
            "startOffset": 19051,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 22853,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "After primary antibody dilution, plates have been incubated for 2 h at 37 \u00b0C.",
            "startOffset": 22776,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 30594,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The activated oligosaccharides were reacted with the different proteins as described in Methods.",
            "startOffset": 30498,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 32243,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Purified conjugates were characterized by SDS\u2013Page (Fig. 5 SI) and for their saccharide and protein content.",
            "startOffset": 32135,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 34725,
            "parents": [],
            "secId": "s0085",
            "sentence": "The increased attention to multivalent combination vaccines and the possible CIES or bystander interference affecting polysaccharide conjugate antigens drives through the need of alternative carrier proteins, which could also be useful to target multiple and different virulence factors (protective epitopes) of pathogens.",
            "startOffset": 34403,
            "title": "Discussion"
        },
        {
            "endOffset": 15371,
            "parents": [],
            "secId": "s0005",
            "sentence": "The strategy was based on two steps: (a) immunogenicity screening in mice of several recombinant proteins conjugated to a model saccharide in comparison to CRM197 as benchmark carrier protein; (b) testing selected carriers conjugated to meningococcal carbohydrate antigens.",
            "startOffset": 15098,
            "title": "Introduction"
        },
        {
            "endOffset": 24025,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0045",
            "sentence": "Pools of sera were tested applying the same procedure described in Section 2.5.1.",
            "startOffset": 23944,
            "title": "Antibody response against the carrier proteins"
        },
        {
            "endOffset": 29275,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The small number of mice in each group and the variability in the immunological response, probably due to the absence of adjuvant in the formulations, limited the ability to highlight statistical significant differences between several carrier proteins and their control.",
            "startOffset": 29004,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 19544,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 19543,
                    "startOffset": 19539
                }
            },
            "secId": "s0025",
            "sentence": "SIDEA-activated Men A, C, W, and Y oligosaccharides and their CRM197 conjugates were obtained from GSK Vaccine Manufacturing, produced as previously described [35].",
            "startOffset": 19380,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 22161,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Coating solutions were removed from the plates by washing three times with PBS buffer with 0.05% v/v of Tween 20 (Sigma) (TPBS).",
            "startOffset": 22033,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 14046,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 13930,
                    "startOffset": 13926
                },
                "b0090": {
                    "endOffset": 14045,
                    "startOffset": 14038
                },
                "b0095": {
                    "endOffset": 14045,
                    "startOffset": 14038
                },
                "b0100": {
                    "endOffset": 14045,
                    "startOffset": 14038
                }
            },
            "secId": "s0005",
            "sentence": "The recombinant non-toxic form of Pseudomonas aeruginosa exotoxin A (rEPA) has been used as carrier for Shigella O-antigens [17] and Staphylococcus aureus type 5 and 8 capsular polysaccahrides as well as for Salmonella Typhi Vi antigen [18\u201320].",
            "startOffset": 13802,
            "title": "Introduction"
        },
        {
            "endOffset": 33905,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This rank corresponds also to the first 20 peptides with high affinity obtained for the amino acidic sequence of CRM197 that is the protein used as benchmark in our studies.",
            "startOffset": 33732,
            "title": "MHC II binding peptides prediction"
        },
        {
            "endOffset": 21477,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Animal experimental guidelines set forth by the Animal Welfare Body of the Animal Resource Centre of our Company have been followed for conducting all animal studies.",
            "startOffset": 21311,
            "title": "Mice immunization"
        },
        {
            "endOffset": 39864,
            "parents": [],
            "secId": "s0085",
            "sentence": "We are accumulating evidences that spr96/2021 can be successfully used as carrier for pneumococcal derived carbohydrates and in meningococcal multivalent formulations, this aspect has not been addressed in this paper and will be part of a comprehensive preclinical investigation.",
            "startOffset": 39585,
            "title": "Discussion"
        },
        {
            "endOffset": 23624,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Each immunization group has been represented as the geometrical mean (GMT) with 95% CI of the single mouse titers.",
            "startOffset": 23510,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 23860,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0045",
            "sentence": "The antibody response induced by the glycoconjugates against the protein has been measured by ELISA.",
            "startOffset": 23760,
            "title": "Antibody response against the carrier proteins"
        },
        {
            "endOffset": 24991,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "The tested sera were pooled and heat-inactivated for 30 min at 56 \u00b0C.",
            "startOffset": 24922,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 23184,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "After three more washes with TPBS, 100 \u03bcl/well of a 1 mg/ml of p-NPP (Sigma) in a 0.5 M di-ethanolammine buffer pH 9.6 was added.",
            "startOffset": 23055,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 12878,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 12877,
                    "startOffset": 12873
                }
            },
            "secId": "s0005",
            "sentence": "The outer membrane protein complex (OMPC) of N. meningitidis serogroup B has been used as carrier for the Hib conjugate vaccine developed by Merck [10].",
            "startOffset": 12726,
            "title": "Introduction"
        },
        {
            "endOffset": 28192,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "This diversity did not correlate with the proportion of lysines on each protein and might be due to their different reactivity depending on local environment.",
            "startOffset": 28034,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 22297,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "A blocking step has been then performed by adding 100 \u03bcl/well of BSA solution at 3% w/v in TPBS and incubating the plates 1 h at 37 \u00b0C.",
            "startOffset": 22162,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 38032,
            "parents": [],
            "secId": "s0085",
            "sentence": "This process might have selected preferentially the protein whose highest affinity T-cell epitopes do not contain lysines in critical position.",
            "startOffset": 37889,
            "title": "Discussion"
        },
        {
            "endOffset": 40743,
            "parents": [],
            "secId": "s0095",
            "sentence": "TM, RMR, MF, BF and CP were involved in the conception and design of the study.",
            "startOffset": 40664,
            "title": "Author contributions"
        },
        {
            "endOffset": 28316,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The conjugates were tested in mice without using any adjuvant in order to highlight the intrinsic value of the carrier only.",
            "startOffset": 28192,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 36312,
            "parents": [],
            "secId": "s0085",
            "sentence": "The response induced by the Men C conjugates with the other selected proteins did not always follow the same trend of the initial screening with Lam.",
            "startOffset": 36163,
            "title": "Discussion"
        },
        {
            "endOffset": 14188,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 14187,
                    "startOffset": 14183
                }
            },
            "secId": "s0005",
            "sentence": "rEPA is also used as a carrier for glycoconjugate vaccines directly synthesized in Escherichia coli against Shigella dysenteriae type 1 [21].",
            "startOffset": 14047,
            "title": "Introduction"
        },
        {
            "endOffset": 32541,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 32416,
                    "startOffset": 32412
                }
            },
            "secId": "s0075",
            "sentence": "The SDS\u2013Page profile of spr96/2021\u2013Men X is similar to the one reported for CRM197\u2013Men X [36] and is consistent with an high molecular weight conjugate and confirmed by the SEC-HPLC analysis reported in SI (Fig. 6 SI).",
            "startOffset": 32323,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 22645,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "200 \u03bcl/well of pre-diluted serum (1:25 for pre immune (negative control), 1:100\u20131:200 for a reference serum and from 1:50 to 1:500 for test sera) was added in the first well of each column of the plate, while on the other wells 100 \u03bcl of TPBS has been dispensed.",
            "startOffset": 22383,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 18825,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "After, the flow through have been taken by using the vacuum air and two washes of the resin have been done with 200 \u03bcl of PBS buffer pH 7.2.",
            "startOffset": 18685,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 14488,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 14487,
                    "startOffset": 14480
                },
                "b0115": {
                    "endOffset": 14487,
                    "startOffset": 14480
                },
                "b0120": {
                    "endOffset": 14487,
                    "startOffset": 14480
                }
            },
            "secId": "s0005",
            "sentence": "A rationally designed recombinant protein containing strings of promiscuous human CD4+ T-cell epitopes derived from various pathogens including tetanus, influenza virus, Plasmodium falciparum and hepatitis B virus, proved to be a very good carrier for Hib and meningococcal oligosaccharides [22\u201324].",
            "startOffset": 14189,
            "title": "Introduction"
        },
        {
            "endOffset": 22775,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Eight two-fold serial dilutions along each column were then performed by transferring from well to well 100 \u03bcl of sera solutions.",
            "startOffset": 22646,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 26775,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 26774,
                    "startOffset": 26764
                },
                "b0200": {
                    "endOffset": 26774,
                    "startOffset": 26764
                },
                "b0205": {
                    "endOffset": 26774,
                    "startOffset": 26764
                }
            },
            "secId": "s0065",
            "sentence": "A panel of twenty-eight proteins derived from different pathogens and expressed recombinantly in E. coli, was conjugated to the neutral sugar Laminarin (Lam), a \u03b2-(1, 3) glucan with sporadic \u03b2-(1, 6) branches, that has been studied as vaccine candidate against C. albicans infections [31,40,41].",
            "startOffset": 26480,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 33568,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Following the indication reported on IEDB, we have chosen 1.5 percentile rank as cut-off for a comparative analysis between the different proteins based on the number of MHC II high affinity peptides.",
            "startOffset": 33368,
            "title": "MHC II binding peptides prediction"
        },
        {
            "endOffset": 23709,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "The statistical and graphical analysis has been done by GraphPad Prism 6.0 software.",
            "startOffset": 23625,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 39448,
            "parents": [],
            "secId": "s0085",
            "sentence": "In conclusion, by screening a large number of recombinant proteins and focusing on two types of saccharide structures, the \u03b2-glucan based non charged Laminarin and the polyanionic meningococcal oligosaccharides, we have identified, based on immunological data, a panel of proteins that deserve further attention.",
            "startOffset": 39136,
            "title": "Discussion"
        },
        {
            "endOffset": 17837,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The activated oligosaccharides were obtained by precipitation with 4 volumes of acetone and dried under vacuum.",
            "startOffset": 17726,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 25861,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "The serum bactericidal titer was defined as the serum dilution resulting in 50% decrease in colony forming units (CFU) per ml, after 60 min incubation of bacteria in the reaction mixture, compared to control CFU per ml at time 0.",
            "startOffset": 25632,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 23364,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Raw data acquisition was performed by Microplate Manager Software (Biorad).",
            "startOffset": 23289,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 19765,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Spr96/2021\u2013Men A, C, W, Y conjugations were carried out in 10\u2013100 mM NaH2PO4 pH 7 or in PBS pH 7 depending on the protein buffer, at a protein concentration of 3\u20133.5 mg/ml and a saccharide to protein molar ratio of 12:1.",
            "startOffset": 19545,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 21727,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "The antibody response induced by the glycoconjugates against the homologous polysaccharide has been measured by ELISA.",
            "startOffset": 21609,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 24315,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "A commercial lot of baby rabbit complement was used as source of active complement.",
            "startOffset": 24232,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 36514,
            "parents": [],
            "secId": "s0085",
            "sentence": "In fact while Upec-5211, Orf3526 and spr1875 conjugates induced anti-Men C CPS IgG titers comparable to CRM197\u2013Men C, spr907, GNA2091-fHbp, RrgB I-II-III conjugates were significantly less immunogenic.",
            "startOffset": 36313,
            "title": "Discussion"
        },
        {
            "endOffset": 40968,
            "parents": [],
            "secId": "s0095",
            "sentence": "All authors were involved in drafting the manuscript or revising it critically for important intellectual content.",
            "startOffset": 40854,
            "title": "Author contributions"
        },
        {
            "endOffset": 17918,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 17917,
                    "startOffset": 17913
                }
            },
            "secId": "s0025",
            "sentence": "The content of N-hydroxysuccinimide ester groups introduced was determined [34].",
            "startOffset": 17838,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 15964,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "CRM197 was provided by the Manufacturing Department (GSK, Siena, Italy).",
            "startOffset": 15892,
            "title": "Reagents"
        },
        {
            "endOffset": 18684,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Conjugates have been loaded on the resin (250 \u03bcg of protein per well in a volume of 200 \u03bcl in the same buffer of conjugation) and incubated for 30 min after gently mixing on the well.",
            "startOffset": 18501,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 27578,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "A CRM197\u2013Lam conjugate was prepared to be used as a control in each immunogenicity study.",
            "startOffset": 27489,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 20547,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The conjugate was purified by ammonium sulfate precipitation (500 g/l) and the pellet was dissolved in 10 mM NaH2PO4 at pH 7.2.",
            "startOffset": 20420,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 24921,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "The total volume in each well was 50 \u03bcl with 25 \u03bcl of serial two-fold dilutions of the test serum, 12.5 \u03bcl of bacteria at the working dilution and 12.5 \u03bcl of baby rabbit complement.",
            "startOffset": 24740,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 36163,
            "parents": [],
            "secId": "s0085",
            "sentence": "The corresponding conjugates induced in mice anti-meningococcal IgGs and rSBA titers comparable to those developed by glycoconjugates of CRM197 which is a well-known carrier and successfully used in several licensed glycoconjugate vaccines like Menjugate\u2122, MENVEO\u2122 and Prevenar (Wyeth).",
            "startOffset": 35877,
            "title": "Discussion"
        },
        {
            "endOffset": 21123,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Lam conjugates were tested at 5 \u03bcg dose, meningococcal conjugates at 2 \u03bcg for Men A and 1 \u03bcg for Men C, W, Y, X.",
            "startOffset": 21011,
            "title": "Mice immunization"
        },
        {
            "endOffset": 24739,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "When bacterial suspensions reached OD600 of 0.25\u20130.27, bacteria were diluted in the assay buffer (Gey\u2019s balanced salt solution with 1% BSA) at the working dilution (ca. 104 CFU/ml).",
            "startOffset": 24558,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 31600,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 31599,
                    "startOffset": 31595
                },
                "b0230": {
                    "endOffset": 31494,
                    "startOffset": 31487
                },
                "b0235": {
                    "endOffset": 31494,
                    "startOffset": 31487
                }
            },
            "secId": "s0075",
            "sentence": "Based on the attractive behavior of spr96/2021 as carrier in both Lam and Men C models, we decided to further explore its potential with the meningococcal serogroups A, W, Y oligosaccharides (Men A, Men W, Men Y), which are currently part of licensed vaccines [46,47], and X polysaccharide (Men X), recently identified as a potential candidate for vaccine development [36].",
            "startOffset": 31227,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 35053,
            "parents": [],
            "secId": "s0085",
            "sentence": "In a first screening step, twenty eight proteins were conjugated to Lam using the end-groups chemistry illustrated in Scheme 1.",
            "startOffset": 34926,
            "title": "Discussion"
        },
        {
            "endOffset": 17652,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 17651,
                    "startOffset": 17647
                }
            },
            "secId": "s0025",
            "sentence": "The amino-oligosaccharides were vacuum dried, solubilized in 1:9 H2O:DMSO solution to a final amino group concentration of 40 \u03bcmol/ml, and reacted with a 12-fold molar excess of adipic acid bis(N-hydroxysuccinimmide) (SIDEA), in presence of 5-fold molar excess triethylamine as compared with amino groups [33].",
            "startOffset": 17342,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 27128,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In addition we have in general preferred proteins with molecular weight between 40 and 100 kDa.",
            "startOffset": 27033,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 35876,
            "parents": [],
            "secId": "s0085",
            "sentence": "Subsequently the potential of spr96/2021 to work as carrier for carbohydrate antigens was confirmed with Men A, Men W, Men Y and Men X.",
            "startOffset": 35741,
            "title": "Discussion"
        },
        {
            "endOffset": 37888,
            "parents": [],
            "secId": "s0085",
            "sentence": "In terms of chemical procedure we should consider that the chemistry used in this work is based on the conjugation to the lysine residues of the proteins.",
            "startOffset": 37734,
            "title": "Discussion"
        },
        {
            "endOffset": 24232,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "refoffsets": {
                "b0190": {
                    "endOffset": 24231,
                    "startOffset": 24227
                }
            },
            "secId": "s0050",
            "sentence": "Functional antibodies induced by vaccine immunization were analyzed by measuring the complement-mediated lysis of N. meningitidis with an in vitro bactericidal assay [38].",
            "startOffset": 24061,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 35327,
            "parents": [],
            "secId": "s0085",
            "sentence": "Since Lam is a non-charged saccharide we thought interesting to extend the study using Men C oligosaccharides which have a negatively charged repeating unit.",
            "startOffset": 35170,
            "title": "Discussion"
        },
        {
            "endOffset": 24414,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Briefly, N. meningitidis strains were grown overnight on chocolate agar plates at 37 \u00b0C in 5% CO2.",
            "startOffset": 24316,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 26225,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Men A, C, W and Y strains are O-acetyl positive.",
            "startOffset": 26177,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 23943,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0045",
            "sentence": "Plates were coated with the different proteins at 2 \u03bcg/ml in PBS buffer at pH 7.2.",
            "startOffset": 23861,
            "title": "Antibody response against the carrier proteins"
        },
        {
            "endOffset": 28033,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The average glycosylation degree of the different glycoconjugates, calculated as saccharide to protein w/w ratio, varied from 1.7 to 0.1 w/w and an example is reported in Table 1.",
            "startOffset": 27854,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 22382,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Blocking solution has been removed from the plates by washing three times with TPBS.",
            "startOffset": 22298,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 38166,
            "parents": [],
            "secId": "s0085",
            "sentence": "Moreover for a given carrier the glycosylation profile obtained with a neutral oligosaccharide might differ from that of charged one.",
            "startOffset": 38033,
            "title": "Discussion"
        },
        {
            "endOffset": 40853,
            "parents": [],
            "secId": "s0095",
            "sentence": "TM, RMR, MF, BF, VM and CP analyzed and interpreted the results.",
            "startOffset": 40789,
            "title": "Author contributions"
        },
        {
            "endOffset": 34402,
            "parents": [],
            "secId": "s0085",
            "sentence": "Few carrier proteins have been tested so far for clinical evaluation of conjugate vaccines and only five of them (DT, TT, CRM197, OMPC and NTHi protein D) are currently used for licensed vaccines against bacterial infections.",
            "startOffset": 34177,
            "title": "Discussion"
        },
        {
            "endOffset": 41089,
            "parents": [],
            "secId": "s0095",
            "sentence": "All authors had full access to the data and approved the manuscript before it was submitted by the corresponding author.",
            "startOffset": 40969,
            "title": "Author contributions"
        },
        {
            "endOffset": 34166,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "We did not find any correlation between the carrier functionality and these results.",
            "startOffset": 34082,
            "title": "MHC II binding peptides prediction"
        },
        {
            "endOffset": 25155,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Negative controls included bacteria incubated, separately, with the complement serum without the test serum and with test sera and the heat-inactivated complement.",
            "startOffset": 24992,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 30497,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The conjugation to Men C oligosaccharides was carried out using the same reaction scheme described above for the Lam conjugates (Scheme 1).",
            "startOffset": 30358,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 19933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Purification has been done by gel filtration or by ultrafiltration as reported above.",
            "startOffset": 19848,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 13324,
            "parents": [],
            "secId": "s0005",
            "sentence": "Multivalent conjugates administration and vaccines co-administration can be associated with immune interference such as carrier-specific enhancement of T-cell help, carrier-induced-epitopic suppression (CIES) or bystander interference.",
            "startOffset": 13089,
            "title": "Introduction"
        },
        {
            "endOffset": 41174,
            "parents": [],
            "secId": "s0100",
            "sentence": "MENVEO and Menjugate are trademarks of the GSK group of companies.",
            "startOffset": 41108,
            "title": "Trademark statement"
        },
        {
            "endOffset": 30049,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "We then decided to test in mice the protein spr96/2021 as carrier for meningococcal serogroup C (Men C) oligosaccharides.",
            "startOffset": 29928,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 15892,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Men X polysaccharide was produced internally by Research Center (GSK, Siena, Italy).",
            "startOffset": 15808,
            "title": "Reagents"
        },
        {
            "endOffset": 12461,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 12460,
                    "startOffset": 12457
                }
            },
            "secId": "s0005",
            "sentence": "Diphtheria (DT) and Tetanus toxoids (TT), derived from the respective toxins after chemical detoxification with formaldehyde, were initially selected as carriers because of the safety track record accumulated with tetanus and diphtheria vaccination [8].",
            "startOffset": 12208,
            "title": "Introduction"
        },
        {
            "endOffset": 17725,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The reaction was kept under gentle stirring at room temperature for 2 h.",
            "startOffset": 17653,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 27032,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The proteins (Table 1 SI) were selected using the following criteria: not expected toxicity based on available information, solubility in physiological buffers at concentrations of 0.4\u20136 mg/ml, and presence of a sufficient number of lysines for conjugation.",
            "startOffset": 26775,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 15415,
            "parents": [],
            "secId": "s0005",
            "sentence": "Here we describe the results of this study.",
            "startOffset": 15372,
            "title": "Introduction"
        },
        {
            "endOffset": 30775,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Also in this case a CRM197\u2013Men C conjugate was prepared to be used as control.",
            "startOffset": 30697,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 12120,
            "parents": [],
            "secId": "s0005",
            "sentence": "In these type of vaccines carbohydrate antigens are covalently bound to a carrier protein which provides T-cell epitopes that confer a T dependent character to the saccharide moiety.",
            "startOffset": 11938,
            "title": "Introduction"
        },
        {
            "endOffset": 13496,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 13495,
                    "startOffset": 13488
                },
                "b0070": {
                    "endOffset": 13495,
                    "startOffset": 13488
                },
                "b0075": {
                    "endOffset": 13495,
                    "startOffset": 13488
                }
            },
            "secId": "s0005",
            "sentence": "Carrier priming and suppression effect were investigated in both animal and human studies and different behaviors between the commonly used carriers were reported [13\u201315].",
            "startOffset": 13325,
            "title": "Introduction"
        },
        {
            "endOffset": 40389,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 40388,
                    "startOffset": 40384
                }
            },
            "secId": "s0085",
            "sentence": "While in the 1980s it was determined more by the discovery phase, impressive technological revolutions made the discovery phase significantly shorter, but at the same time the development path which includes process development, clinical and regulatory development, and GMP manufacturing is longer and fully justified by increased cGMP and good clinical practice standards, making the overall time to market still in the range of 10\u201315 years [48].",
            "startOffset": 39942,
            "title": "Discussion"
        },
        {
            "endOffset": 40644,
            "parents": [],
            "secId": "s0090",
            "sentence": "Tontini M., Romano M. R., Proietti D., Micoli F., Balocchi C., Masignani V., Berti F. and Costantino P. were listed as an inventor on patents owned by the GSK group of companies.",
            "startOffset": 40466,
            "title": "Conflict of interests"
        },
        {
            "endOffset": 16709,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "All the proteins tested are reported in Table 1 SI with bacteria origin, protein name and alternative name reported in the bracket.",
            "startOffset": 16578,
            "title": "Preparation of protein carriers"
        },
        {
            "endOffset": 20118,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The same conditions were applied to obtain the conjugates between Men C activated oligosaccharides and the proteins Upec-5211, Orf3526, GNA2091-fHbp, RrgB I-II-III, spr907 and spr1418.",
            "startOffset": 19934,
            "title": "Preparation of conjugates"
        },
        {
            "endOffset": 21925,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0040",
            "sentence": "Plates have been coated with the different meningococcal polysaccharides by adding 100 \u03bcl/well of a 5 \u03bcg/ml polysaccharide solution in PBS buffer at pH 8.2 followed by incubation overnight at 4 \u00b0C.",
            "startOffset": 21728,
            "title": "Antibody response induced by the glycoconjugates against the homologous polysaccharide"
        },
        {
            "endOffset": 25310,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Immediately after the addition of the baby rabbit complement, negative controls were plated on Mueller\u2013Hinton agar plates, using the tilt method (time 0).",
            "startOffset": 25156,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 32322,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The glycosylation degrees were in the range between 0.7 and 0.2 w/w (Table 2).",
            "startOffset": 32244,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 33073,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "When tested in mice, the spr96/2021\u2013Men A, W,Y and X based conjugates, after three doses of vaccine, were able to induce a level of specific anti-Men IgGs substantially comparable with that of CRM197 conjugates (p > 0.05; p = 0.2620; Fig. 3).",
            "startOffset": 32831,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 29003,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In Fig. 3 SI we have reported the immunogenicity of all the Lam conjugates expressed as the difference between the median of each group and the median of the relative control group CRM197\u2013Lam.",
            "startOffset": 28811,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 29619,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0210": {
                    "endOffset": 29432,
                    "startOffset": 29425
                },
                "b0215": {
                    "endOffset": 29432,
                    "startOffset": 29425
                },
                "b0220": {
                    "endOffset": 29432,
                    "startOffset": 29425
                }
            },
            "secId": "s0065",
            "sentence": "Since spr96/2021 is a recombinant fusion of the two pneumococcal proteins spr0096 (LysM domain secreted protein) and spr2021 (secreted PcsB protein) [42\u201344], we addressed the question whether one of the two moieties could be responsible for this strong carrier effect and we tested in mice Lam conjugates with spr0096 and spr2021 respectively.",
            "startOffset": 29276,
            "title": "Screening of potential new carrier proteins using Lam as carbohydrate pilot model"
        },
        {
            "endOffset": 33331,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The functionality of the antibodies elicited by the spr96/2021 glycoconjugates against each meningococcal bacterial strain was comparable with that induced by CRM197 conjugates, as determined by rabbit complement mediated bactericidal assay (rSBA) (Table 3).",
            "startOffset": 33073,
            "title": "Evaluation of spr96/2021 as carrier for serogroup A, W, Y, and X meningococcal saccharides"
        },
        {
            "endOffset": 15690,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Laminarin was obtained from Sigma Aldrich (L9634).",
            "startOffset": 15640,
            "title": "Reagents"
        },
        {
            "endOffset": 35169,
            "parents": [],
            "secId": "s0085",
            "sentence": "The protein spr96/2021 emerged as a promising carrier inducing titers significantly higher than CRM197\u2013Lam (Fig. 1).",
            "startOffset": 35053,
            "title": "Discussion"
        },
        {
            "endOffset": 25631,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0035",
                    "title": "Analysis of antibody response by ELISA"
                }
            ],
            "secId": "s0050",
            "sentence": "Agar plates were incubated overnight at 37 \u00b0C and the colonies corresponding to time 0 and time 1 (surviving bacteria) were counted.",
            "startOffset": 25499,
            "title": "Serum bactericidal assay (rSBA)"
        },
        {
            "endOffset": 30357,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 30328,
                    "startOffset": 30324
                }
            },
            "secId": "s0070",
            "sentence": "We also included in the evaluation other seven proteins, among those initially tested in the Lam model, whose median of the anti Lam response was similar, intermediate or low when compared to their CRM197\u2013Lam control: Orf3526 and spr907, Upec-5211 and spr1418, GNA2091-fHbp [45], RrgB I-II-III, and spr1875.",
            "startOffset": 30050,
            "title": "Evaluation of selected proteins as carrier for serogroup C meningococcal oligosaccharide"
        },
        {
            "endOffset": 35591,
            "parents": [],
            "secId": "s0085",
            "sentence": "Accordingly spr96/2021 and also some other proteins of those initially tested in the Lam model and showing similar, intermediate or low median anti Lam response as compared to their CRM197\u2013Lam control, were conjugated to Men C oligosaccharides and tested in mice.",
            "startOffset": 35328,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X16304637",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "M.",
                "initial": "M.",
                "last": "Tontini"
            },
            {
                "email": null,
                "first": "M. R.",
                "initial": "M.R.",
                "last": "Romano"
            },
            {
                "email": null,
                "first": "D.",
                "initial": "D.",
                "last": "Proietti"
            },
            {
                "email": null,
                "first": "E.",
                "initial": "E.",
                "last": "Balducci"
            },
            {
                "email": null,
                "first": "F.",
                "initial": "F.",
                "last": "Micoli"
            },
            {
                "email": null,
                "first": "C.",
                "initial": "C.",
                "last": "Balocchi"
            },
            {
                "email": null,
                "first": "L.",
                "initial": "L.",
                "last": "Santini"
            },
            {
                "email": null,
                "first": "V.",
                "initial": "V.",
                "last": "Masignani"
            },
            {
                "email": null,
                "first": "F.",
                "initial": "F.",
                "last": "Berti"
            },
            {
                "email": "paolo.x.costantino@gsk.com",
                "first": "P.",
                "initial": "P.",
                "last": "Costantino"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.06.039",
        "firstpage": "4235",
        "issn": "0264410X",
        "keywords": [
            "CRM197",
            "Carrier protein",
            "Glycoconjugates",
            "Meningococcal vaccines"
        ],
        "lastpage": "4242",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Preclinical studies on new proteins as carrier for glycoconjugate vaccines"
    }
}